Form 4: BioLife Solutions CFO Sells Shares to Cover Tax Obligations

BioLife Solutions Inc.'s Chief Financial Officer, Troy Wichterman, sold 1,042 shares of common stock for $23.7 per share to satisfy tax withholding obligations related to restricted stock vesting.

Summary

• Troy Wichterman, Chief Financial Officer of BioLife Solutions Inc. (BLFS), reported a sale of common stock.
• The transaction occurred on June 10, 2025.
• A total of 1,042 shares were sold at a price of $23.7 per share.
• Following this transaction, Mr. Wichterman beneficially owns 186,685 shares of common stock.
• The sale was executed under a Rule 10b5-1(c) trading plan, adopted on March 8, 2024, specifically to cover tax withholding obligations arising from the vesting of restricted stock.

Sentiment

Score: 5

Explanation: The transaction is a routine, non-discretionary sale for tax purposes, which is neutral in sentiment. It does not indicate a change in management's outlook on the company.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• The sale reported herein was made pursuant to a Rule 10b5-1 (c) trading plan adopted by the reporting person effective as of 03-08-2024 to satisfy tax withholding obligations in connection with the vesting of shares of restricted stock.

Industry Context

This document is an insider transaction report (Form 4) and does not provide information related to broader industry trends or competitors.

Stakeholder Impact

• Shareholders: The sale represents a minor dilution of shares but is a routine event for executive compensation and tax management, unlikely to have a significant direct impact on share price or company valuation.

Key Dates

Keywords

BioLife Solutions, BLFS, Form 4, Insider Trading, Stock Sale, CFO, Troy Wichterman, Tax Withholding, Restricted Stock, 10b5-1 Plan